Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain

Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain

Bibliographic Details
Main Authors:	Martinez-Raga, Jose, Gonzalez-Saiz, Francisco, Oñate, Julian, Oyagüez, Itziar, Sabater, Eliazar, Casado, Miguel A
Format:	Online
Language:	English
Published:	Springer 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402931/

Similar Items

Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain
by: Jiménez-Ruiz, Carlos A, et al.
Published: (2015)

Buprenorphine Outpatient Outcomes Project: can Suboxone be a viable outpatient option for heroin addiction?
by: Sittambalam, Charmian D., et al.
Published: (2014)

Cost analysis of glatiramer acetate vs. fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis in Spain
by: Sanchez-de la Rosa, Rainel, et al.
Published: (2013)

Injecting buprenorphine-naloxone film: Findings from an explorative qualitative study
by: White, N., et al.
Published: (2015)

Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment
by: Barry, Declan T., et al.
Published: (2007)

Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy
by: Tofighi, Babak, et al.
Published: (2014)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
by: Mauger, Sofie, et al.
Published: (2014)

Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote population
by: Jumah, Naana Afua, et al.
Published: (2016)

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
by: Gawronski, Kristen M, et al.
Published: (2014)

Low-dose naloxone provides an abuse-deterrent effect to buprenorphine
by: Webster, Lynn R, et al.
Published: (2015)

Evaluation of drug-drug interaction between daclatasvir and methadone or buprenorphine/naloxone
by: Garimella, Tushar, et al.
Published: (2014)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
by: Soyka, Michael
Published: (2015)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
by: Lund, Ingunn O., et al.
Published: (2013)

Comment on “A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes”
by: Newman, Robert G., et al.
Published: (2013)

Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: a systematic review
by: Echave, María, et al.
Published: (2014)

Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech
by: Hill, Edward, et al.
Published: (2013)

Correction: Long Term Suboxone™ Emotional Reactivity As Measured by Automatic Detection in Speech
by: Hill, Edward, et al.
Published: (2013)

Patients that benefit from buprenorphine-naloxone on medically assisted treatment for opioid dependence in Malaysia
by: Azhanie Sardangi
Published: (2015)

Psychological Barriers to Tobacco Cessation in Indian Buprenorphine-Naloxone Maintained Patients: A Pilot Study
by: Mandal, Piyali, et al.
Published: (2015)

Correlates of Nine-Month Retention following Interim Buprenorphine-Naloxone Treatment in Opioid Dependence: A Pilot Study
by: Håkansson, A., et al.
Published: (2016)

Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine/naloxone tablet formulation in healthy volunteers
by: Fischer, Andreas, et al.
Published: (2015)

Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film
by: Gunderson, Erik W., et al.
Published: (2016)

Buprenorphine
by: Mazurek, Jaroslaw, et al.
Published: (2014)

Budgetary reforms
by: Pamela, Edwards, et al.
Published: (2005)

Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs
by: Homar, Francesc, et al.
Published: (2012)

Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain
by: Rodríguez González-Moro, Jose Miguel, et al.
Published: (2015)

Role of buprenorphine in prolonging the duration of post-operative analgesia in percutaneous nephrolithotomy: Comparison between bupivacaine versus bupivacaine and buprenorphine combination
by: Nirmala, Jonnavithula, et al.
Published: (2015)

Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls
by: Rapeli, Pekka, et al.
Published: (2007)

Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)
by: Kunøe, Nikolaj, et al.
Published: (2016)

Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis
by: Gros, Blanca, et al.
Published: (2015)

Budgeting and budgetary control system.
by: Ong, Tze San
Published: (2013)

Budgeting and Budgetary Institutions
by: Shah, Anwar
Published: (2012)

The case for fair budgetary procedures
by: Nace R., Magner, et al.
Published: (2006)

Budgetary practices and accountability habitus
by: Andrew, Goddard
Published: (2004)

Theories of budgetary tradeoffs
by: Alex, Mintz, et al.
Published: (1995)

Recent budgetary reforms in singapore
by: David Seth, Jones
Published: (1998)

User evaluation by budgetary games
by: C.C., Parker
Published: (1979)

Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain
by: Grau, Santiago, et al.
Published: (2012)

Use of naloxone in valproate overdose
by: Sanaei-Zadeh, Hossein
Published: (2012)

Effects of naloxone on phagocyte functions
by: Delvaux, B, et al.
Published: (2006)